News
Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...
The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...
The FDA approved Yutrepia inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension ...
An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...
Adults with obesity using a GLP-1 have a similar risk for obesity-related cancers as those who undergo bariatric surgery, ...
Long-term outcomes after CT or invasive coronary angiography to diagnose CAD were similar, with comparable improvement in ...
A combination of unsupervised and supervised machine learning algorithms may be able to assist clinicians in identifying ...
Adolescents with mental health issues who were admitted to a pediatric inpatient psychiatry unit experienced significant ...
Drug and alcohol references in popular music not only correlate with use, but they also provide opportunities for engaging ...
In ALS, a neurodegenerative condition that leads to loss of muscle control and executive function, there is a need for ...
Patients with COPD and type 2 inflammation receiving mepolizumab vs. placebo had decreased moderate and severe exacerbation ...
Children and young adults in states with high Medicaid disenrollment rates were more likely to experience disruptions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results